Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients (PICS)

This study has been completed.
Arthritis and Rheumatic Disease Specialties
UCB Pharma
Information provided by (Responsible Party):
Ewa Olech, Oklahoma Medical Research Foundation Identifier:
First received: September 29, 2010
Last updated: March 7, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)